首页> 外文期刊>BMC Cancer >After accounting for competing causes of death and more advanced stage, do Aboriginal and Torres Strait Islander peoples with cancer still have worse survival? A population-based cohort study in New South Wales
【24h】

After accounting for competing causes of death and more advanced stage, do Aboriginal and Torres Strait Islander peoples with cancer still have worse survival? A population-based cohort study in New South Wales

机译:在考虑到死亡的竞争原因和更晚期的疾病之后,原住民和托雷斯海峡岛民癌症患者的生存率是否仍较差?新南威尔士州一项基于人群的队列研究

获取原文
获取外文期刊封面目录资料

摘要

Background Aboriginal and Torres Strait Islander peoples in Australia have been found to have poorer cancer survival than non-Aboriginal people. However, use of conventional relative survival analyses is limited due to a lack of life tables. This cohort study examined whether poorer survival persist after accounting for competing risks of death from other causes and disparities in cancer stage at diagnosis, for all cancers collectively and by cancer site. Methods People diagnosed in 2000–2008 were extracted from the population-based New South Wales Cancer Registry. Aboriginal status was multiply imputed for people with missing information (12.9%). Logistic regression models were used to compute odds ratios (ORs) with 95% confidence intervals (CIs) for ‘advanced stage’ at diagnosis (separately for distant and distant/regional stage). Survival was examined using competing risk regression to compute subhazard ratios (SHRs) with 95%CIs. Results Of the 301,356 cases, 2517 (0.84%) identified as Aboriginal (0.94% after imputation). After adjusting for age, sex, year of diagnosis, socio-economic status, remoteness, and cancer site Aboriginal peoples were more likely to be diagnosed with distant (OR 1.30, 95%CI 1.17–1.44) or distant/regional stage (OR 1.29, 95%CI 1.18–1.40) for all cancers collectively. This applied to cancers of the female breast, uterus, prostate, kidney, others (those not included in other categories) and cervix (when analyses were restricted to cases with known stages/known Aboriginal status). Aboriginal peoples had a higher hazard of death than non-Aboriginal people after accounting for competing risks from other causes of death, socio-demographic factors, stage and cancer site (SHR 1.40, 95%CI 1.31–1.50 for all cancers collectively). Consistent results applied to colorectal, lung, breast, prostate and other cancers. Conclusions Aboriginal peoples with cancer have an elevated hazard of cancer death compared with non-Aboriginal people, after accounting for more advanced stage and competing causes of death. Further research is needed to determine reasons, including any contribution of co-morbidity, lifestyle factors and differentials in service access to help explain disparities.
机译:背景技术澳大利亚的原住民和托雷斯海峡岛民比非原住民的癌症生存率低。然而,由于缺乏生命表,常规相对生存分析的使用受到限制。这项队列研究检查了所有癌症(按癌症部位和癌症部位)诊断后在癌症阶段的其他原因和差异造成的死亡竞争风险后,是否仍存在较差的生存率。方法2000-2008年确诊的人来自以人口为基础的新南威尔士州癌症登记处。缺少信息的人的原住民身份被多次估算(12.9%)。 Logistic回归模型用于在诊断时针对“高级阶段”(分别针对远距离和远距离/区域阶段)计算具有95%置信区间(CI)的比值比(OR)。使用竞争风险回归分析生存率,以计算具有95%CI的亚危险比(SHR)。结果在301,356例病例中,有2517例(0.84%)被确定为原住民(插补后为0.94%)。在调整了年龄,性别,诊断年份,社会经济地位,偏远性和癌症部位后,原住民更有可能被诊断为远处(OR 1.30,95%CI 1.17-1.44)或远处/区域性阶段(OR 1.29) ,对于所有癌症而言,均为95%CI 1.18-1.40)。这适用于女性乳腺癌,子宫癌,前列腺癌,肾癌,其他癌症(未包括在其他类别中)和子宫颈癌(当分析仅限于已知阶段/已知原住民状况的病例时)。在考虑了其他死亡原因,社会人口统计学因素,阶段和癌症部位的竞争风险之后,土著居民的死亡危险比非土著人更高(SHR 1.40,所有癌症的总和为95%CI 1.31-1.50)。一致的结果应用于大肠癌,肺癌,乳腺癌,前列腺癌和其他癌症。结论与非原住民相比,原住民癌症患者的癌症死亡风险更高,这是因为他们考虑了更晚期和死亡原因。需要进一步的研究来确定原因,包括并发疾病,生活方式因素和服务获取差异的任何原因,以帮助解释差异。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号